ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer -- Hagens Berman

On September 10, 2025, investors in Synopsys, Inc. (NASDAQ: SNPS) saw the price of their shares crater over $216 (-36%) after the company reported its Q3 2025 financial results and revealed significant problems with a major foundry customer.

The development has prompted national shareholders rights firm Hagens Berman to open an investigation into whether Synopsys may have misled investors about its customer risks and growth prospects.

The firm urges investors in Synopsys who suffered significant losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Visit:

www.hbsslaw.com/investor-fraud/snps

Contact the Firm Now:

SNPS@hbsslaw.com

 

844-916-0895

Synopsys, Inc. (SNPS) Investigation:

In the past Synopsys has assured investors that, while its largest customer (Intel) had reduced its R&D spend, “it does not impact generally the EDA software[]” and downplayed risks based on its “committed, non-cancellable” agreements with Intel involving a mix of EDA software, IP, and hardware.

The company’s assurances may have come into question on September 9, 2025, when Synopsys reported its Q3 2025 financial results and shockingly guided for Q4 2025 GAAP EPS of negative $0.27 to negative $0.16.

During the earnings call, management revealed the company’s underperformance in its IP business and said it was significantly due to “challenges at a major foundry customer” that is “also having a sizeable impact on the year[.]”

This news drove the price of Synopsys shares down 36% the next day, its worst-ever single-day percentage decline since going public in 1992.

“We’re investigating whether Synopsys may have misled investors about risks posed by its high concentration with a single customer,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Synopsys and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the Synopsys investigation, read more »

Whistleblowers: Persons with non-public information regarding Synopsys should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email SNPS@hbsslaw.com.

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Reed Kathrein, 844-916-0895

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.